Quanterix Corporation Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Quanterix Corporation stock issued during period, value, stock options exercised for the quarter ending 2023-03-31 was $13.00K, a 96.62% decline year-over-year.
- Quanterix Corporation stock issued during period, value, stock options exercised for the quarter ending 2022-12-31 was $714.00K, a 37.53% decline year-over-year.
- Quanterix Corporation stock issued during period, value, stock options exercised for the quarter ending 2022-09-30 was $120.00K, a 89.46% decline year-over-year.
- Quanterix Corporation stock issued during period, value, stock options exercised for the quarter ending 2022-06-30 was $211.00K, a 91.18% decline year-over-year.
- Quanterix Corporation stock issued during period, value, stock options exercised for fiscal 2022 was $1.43M, a 81.55% decline from fiscal 2021.
- Quanterix Corporation stock issued during period, value, stock options exercised for fiscal 2021 was $7.75M, a 92.83% increase from fiscal 2020.
- Quanterix Corporation stock issued during period, value, stock options exercised for fiscal 2020 was $4.02M.
- Quanterix Corporation stock issued during period, value, stock options exercised for fiscal 2016 was $213.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2023-03-31 | $13.00K 10-Q · filed 2023-05-09 | $1.06M derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | $714.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $1.43M 10-K · filed 2023-03-06 |
| 2022-09-30 | $120.00K 10-Q · filed 2022-11-09 | $1.86M derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-06-30 | $211.00K 10-Q · filed 2022-08-08 | $2.88M derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-03-31 | $385.00K 10-Q · filed 2023-05-09 | $5.06M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $7.75M 10-K · filed 2023-03-06 |
| 2021-09-30 | $1.14M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $2.39M 10-Q · filed 2022-08-08 | |
| 2021-03-31 | $3.08M 10-Q · filed 2022-05-10 | |
| 2020-12-31 | $4.02M 10-K · filed 2023-03-06 | |
| 2016-12-31 | $213.00K 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |